Skip to content

Abivax

  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • ABTECT
  • Pipeline
    • Overview
    • Patients
    • Obefazimod for UC
    • Obefazimod for Crohn’s
    • Obefazimod for RA
    • ABX196 for HCC
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Overview
    • Share Price
    • Investor Documents
    • General Meeting
  • Contact Us
Search
  • EN
  • FR
  • DE

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

LabioTech

September 28, 2017

Study Results Confirm that Abivax’s HIV Cure Gets Rid of Virus

Labiotech

September 28, 2017

Study Results Confirm that Abivax’s Treatment Towards an HIV Cure Gets Rid of Virus

Pharmaphorum

September 28, 2017

Abivax claims progress towards HIV cure

BioCentury

May 12, 2017

Stepwise to a cure

European Biotechnology

May 5, 2017

Abivax’ shares jump on new Phase IIa HIV data

  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 46
© 2023 All rights reserved by ABIVAX | Website created by Stratégie et communication digitale : JLL CONSEIL Privacy and Terms of Use
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Obefazimod for UC
    • ABX196 for HCC
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Share Profile
    • Share Price
    • Investor Documents
    • Analysts
    • General Meeting
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Google+